Risk of venous thromboembolism with use of combined oral contraceptives
Saguil, A.
American Family Physician 91(5): 287-288
2015
ISSN/ISBN: 1532-0650 PMID: 25822383 Document Number: 626244
Document emailed within 1 workday
Related Documents
Vinogradova, Y.; Coupland, C.; Hippisley-Cox, J. 2015: Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases Bmj 350: H2135Nightingale, A.L.; Lawrenson, R.A.; Simpson, E.L.; Williams, T.J.; MacRae, K.D.; Farmer, R.D. 2000: The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 5(4): 265-274
Plu-Bureau, Gève. 2015: Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills Evidence-Based Medicine 20(5): 189
Machado, Rério.Bonassi.; Morimoto, M.; Santana, N.; Arruda, Lívia.Fernandes.; Bernardes, C.Rejane.; de Souza, I.Matias. 2015: Effect of information on the perception of users and prospective users of combined oral contraceptives regarding the risk of venous thromboembolism Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(1): 57-60
Jick, S.S.; Hernandez, R.K. 2011: Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data Bmj 342: D2151
Brown, D.A.; Vartan, C.M. 2011: Risk of venous thromboembolism with drospirenone-containing oral contraceptives American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(11): 1003-1010
Dinger, J.ür.; Shapiro, S. 2012: Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets Journal of Family Planning and Reproductive Health Care 38(1): 2-6
Suissa, S.; Blais, L.; Spitzer, W.O.; Cusson, J.; Lewis, M.; Heinemann, L. 1997: First-time use of newer oral contraceptives and the risk of venous thromboembolism Contraception 56(3): 141-146
Maling, T.J. 1999: Third generation oral contraceptives and the risk of venous thromboembolism: management of the uncertainty New Zealand Medical Journal 112(1094): 305-307
Shapiro, S. 2013: Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases Journal of Family Planning and Reproductive Health Care 39(2): 89-96
Milsom, I.; Odlind, V.; von Schoultz, B.; Ostlund, I.; Persson, E. 2002: Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations Lakartidningen 99(1-2): 10-2 15
Lidegaard, Øj.; Nielsen, L.H.; Skovlund, C.W.; Skjeldestad, F.E.; Løkkegaard, E. 2011: Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9 Bmj 343: D6423
Milsom, I.; Odlind, V.; von Schoultz, B.; Ostlund, I.; Persson, E. 2002: Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations Lakartidningen 99(1-2): 10-2 15
Odlind, V.; Milsom, I.; Persson, I.; Victor, A. 2002: Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstetricia et Gynecologica Scandinavica 81(6): 482-490
Rosa, M.Inês.; Madeira, K.; Medeiros, L.Rosi. 2013: Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 18(2): 137-139
Rosa, M.Inês.; Madeira, K.; Medeiros, L.Rosi. 2013: Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 18(2): 137-139
Hannaford, P.C. 2011: The progestogen content of combined oral contraceptives and venous thromboembolic risk Bmj 343: D6592
Jick, S.S.; Hagberg, K.W.; Hernandez, R.K.; Kaye, J.A. 2010: Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism Contraception 81(1): 16-21
Sandset, P.Morten. 2014: Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen Evidence-Based Medicine 19(5): 194
Paul, C. 1996: Oral contraceptives and venous thromboembolism New Zealand Medical Journal 109(1033): 413-415